APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia ; volume:14 ; number:1 ; day:30 ; month:3 ; year:2022 ; pages:1-11 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (30.3.2022), 1-11, 12.2022
- Urheber
-
Blackman, Jonathan
Love, Seth
Sinclair, Lindsey
Cain, Richard
Coulthard, Elizabeth
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-022-00992-y
- URN
-
urn:nbn:de:101:1-2022061908271292196245
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blackman, Jonathan
- Love, Seth
- Sinclair, Lindsey
- Cain, Richard
- Coulthard, Elizabeth
- SpringerLink (Online service)
Ähnliche Objekte (12)
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers
Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer’s disease by interacting with APOE ε4
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers
Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer’s disease by interacting with APOE ε4
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers